Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Spectral Medical Inc T.EDT

Alternate Symbol(s):  EDTXF

Spectral develops devices for unmet medical needs. Sepsis occurs in 1.7M Americans/year causing 250K deaths, often caused by endotoxin. Our devices measure and remove endotoxin from the bloodstream. An FDA confirmatory trial is underway. Dialco, a Spectral sub, offers SAMI, a novel instrument for renal replacement, cleared by FDA. Dialco is seeking FDA approval for DIMI a unique home dialysis enabler. These devices have large commercial potential


TSX:EDT - Post by User

Post by mercedesmanon Aug 10, 2020 1:13pm
308 Views
Post# 31388204

Global Sepsis Deaths are double previous estimates...

Global Sepsis Deaths are double previous estimates...https://www.usnews.com/news/best-countries/articles/2020-01-16/global-sepsis-deaths-are-double-previous-estimates

Article using stats pre- Covid-19

The study, led by researchers at the University of Pittsburgh and University of Washington schools of medicine, found 48.9 million global cases of sepsis and 11 million deaths in 2017, which is nearly 20% of all fatalities, according to a news release accompanying the study. The new numbers are roughly double the leading previous estimate published in 2016, says Dr. Kristina Rudd, assistant professor in the University of Pittsburgh Department of Critical Care Medicine and lead author of the study.

What if 10 % of the world's actual (not suspected) Sepsis cases got a (single!) EAA reading (to ascertain endotoxin levels and or a proposed treatment plan).  Note: same as 3% getting an average of 3 readings throughout hosptial stay/treatment..

48.9M x .10 = 4.9M EAA tests

X $200 USD per test  (latest estimate from prior presentations)

= $980,000,000 USD

= $ 1.3 B CAD 

= $ 5.21 Rev/share. (based on 250M shares o/s)


Guess as to the margin on the EAA test (the only FDA approved test for Endotoxins/Sepsis) for which Spectral has the world-wide rights?

MM
<< Previous
Bullboard Posts
Next >>